TEVA - TEVA PHARMACEUTICAL COMMON STOCK
This page shows which of the focused investors we track hold TEVA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2011 it was held by 6 managers with an aggregate reported value of $63.08M, which is 0.01% of the combined portfolio.
As of Q2 2011, 6 tracked institutional managers held TEVA (TEVA PHARMACEUTICAL COMMON STOCK) with an aggregate reported value of $63.08M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades TEVA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2011
- Ticker
- TEVA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | David Rolfe - Wedgewood Partners | 4.81% | Add +82.5% | 733,717 | $35.22M |
| 2 | Thomas Gayner - Markel Asset Management | 1.39% | Add +76.8% | 252,100 | $12.16M |
| 3 | David Katz - Matrix Asset Advisors | 1.02% | New | 181,980 | $8.78M |
| 4 | Bill Miller - Miller Value Partners | 0.35% | New | 132,800 | $6.66M |
| 5 | Valley Forge Capital Management - Valley Forge Capital Management | 4.38% | New | 5,301,594 | $256K |
| 6 | First Eagle - First Eagle Investment Management | 0.00% | - | 200 | $10K |
Loading holder history for TEVA…